JWA
RYTM icon

JFS Wealth Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

JFS Wealth Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed -$870 – 2290
2026
Q1 		$870 Hold
10
– – ﹤0.01% 1689
2025
Q4 		$1.07K Buy
+10
New +$1.06K ﹤0.01% 1692

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JFS Wealth Advisors's RYTM Position: Q2 2026 in Review

JFS Wealth Advisors sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 10 shares — an estimated $870 sold.

JFS Wealth Advisors first reported a position in RYTM in Q4 2025 and held it in 2 quarters. The position peaked at $1.07K in Q4 2025. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • JFS Wealth Advisors reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • JFS Wealth Advisors sold 10 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $870.
  • JFS Wealth Advisors first reported a position in Rhythm Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • JFS Wealth Advisors's Rhythm Pharmaceuticals position peaked at $1.07K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.